MATERNAL SERUM HUMAN CHORIONIC-GONADOTROPIN AND PREGNANCY-ASSOCIATED PLASMA PROTEIN-A, MARKERS FOR FETAL DOWN-SYNDROME AT 8-14 WEEKS

被引:50
作者
MACINTOSH, MCM
ILES, R
TEISNER, B
SHARMA, K
CHARD, T
GRUDZINSKAS, JG
WARD, RHT
MULLER, F
机构
[1] STATE SERUM INST,DIV IMMUNOL,COPENHAGEN,DENMARK
[2] ST BARTHOLOMEWS HOSP,COLL MED,DEPT REPROD PHYSIOL,LONDON EC1A 7BE,ENGLAND
[3] UNIV LONDON LONDON HOSP,COLL MED,LONDON E1 1BB,ENGLAND
[4] UNIV COLL HOSP LONDON,DEPT OBSTET & GYNAECOL,LONDON EC1A 7BE,ENGLAND
[5] HOP AMBROISE PARE,BIOCHEM LAB,F-92104 BOULOGNE,FRANCE
关键词
HUMAN CHORIONIC GONADOTROPIN (HCG); PREGNANCY-ASSOCIATED PLASMA PROTEIN-A (PAPP-A); SCREENING; DOWN SYNDROME;
D O I
10.1002/pd.1970140311
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Maternal serum levels of human chorionic gonadotrophin and its subunits (intact, alpha, and free betahCG) and pregnancy-associated plasma protein A (PAPP-A) were measured in 279 women between 8 and 14 weeks' gestation. This group included 23 pregnancies in which the fetus had Down syndrome (DS), diagnosed either at birth or during the second trimester (n = 17) or from chorionic villus sampling (CVS) (n = 6). Normal medians were determined from the 258 apparently normal pregnancies. The median levels of intact hCG (1.4 MOM) and free betahCG (2.1 MOM) were significantly raised, whereas the median level of PAPP-A (0.39 MOM) was significantly lower in the DS pregnancies when compared with the control group. Levels of alphahCG were similar in both the control and the DS pregnancies. Analysis of samples taken prior to 14 weeks' gestation demonstrated that only PAPP-A (0.34 MOM) was significantly altered in DS pregnancies. However, after the exclusion of DS cases diagnosed at CVS, the median intact hCG (1.56 MOM), free betahCG (2-27 MOM), and alphahCG (1.8 MOM) were all raised in DS pregnancies. This emphasizes the problem of the interpretation of biochemical markers when DS cases are diagnosed at CVS.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 27 条
  • [1] BARKAI G, 1987, LANCET, V2, P389
  • [2] HUMAN CHORIONIC-GONADOTROPIN LEVELS IN PREGNANCIES WITH ANEUPLOID FETUSES
    BOGART, MH
    GOLBUS, MS
    SORG, ND
    JONES, OW
    [J]. PRENATAL DIAGNOSIS, 1989, 9 (06) : 379 - 384
  • [3] BRAMBATI B, 1986, LANCET, V2, P165
  • [4] BRAMBATI B, IN PRESS BR J OBSTET
  • [5] 1ST-TRIMESTER MATERNAL SERUM BIOCHEMICAL INDICATORS IN DOWN SYNDROME
    BROCK, DJH
    BARRON, L
    HOLLOWAY, S
    LISTON, WA
    HILLIER, SG
    SEPPALA, M
    [J]. PRENATAL DIAGNOSIS, 1990, 10 (04) : 245 - 251
  • [6] 1ST-TRIMESTER MATERNAL SERUM UNCONJUGATED ESTRIOL AND ALPHA-FETOPROTEIN IN FETAL DOWNS-SYNDROME
    CRANDALL, BF
    GOLBUS, MS
    GOLDBERG, JD
    MATSUMOTO, M
    [J]. PRENATAL DIAGNOSIS, 1991, 11 (06) : 377 - 380
  • [7] CUCKLE HS, 1988, LANCET, V2, P851
  • [8] MATERNAL AGE SPECIFIC RATES FOR CHROMOSOME-ABERRATIONS AND FACTORS INFLUENCING THEM - REPORT OF A COLLABORATIVE EUROPEAN STUDY ON 52965 AMNIOCENTESES
    FERGUSONSMITH, MA
    YATES, JRW
    [J]. PRENATAL DIAGNOSIS, 1984, 4 : 5 - 44
  • [9] COMPARISON OF CIRCULATING GLYCOPROTEIN HORMONES AND THEIR SUBUNITS IN PATIENTS WITH OAT CELL-CARCINOMA OF LUNG AND UREMIC PATIENTS ON CHRONIC DIALYSIS
    HAGEN, C
    GILBY, ED
    MCNEILLY, AS
    OLGAARD, K
    BONDY, PK
    REES, LH
    [J]. ACTA ENDOCRINOLOGICA, 1976, 83 (01): : 26 - 35
  • [10] HURLEY PA, 1993, IN PREESS PRENAT DIA